Pattern of Adverse Drug Reactions to Covishield Vaccine among the Faculty of a Tertiary Care Teaching Hospital in Jaipur City

Pattern of Adverse Drug Reactions to Covishield Vaccine among the Faculty of a Tertiary Care Teaching Hospital in Jaipur City

Introduction: This study aims to evaluate the pattern of adverse drug reaction to Covishield vaccine which is being given to faculty doctors at SMS Medical College in Jaipur city. Methodology: A pre-validated questionnaire was circulated through e-mail to all the faculty members. Results: A total of...

Full description

Bibliographic Details
Main Author:	Rupa Kapadia; Monica Jain; Lokendra Sharma; Kopal Sharma
Format:	Article
Language:	English
Published:	Sonali Sharma on behalf of Rajasthan University of Health Sciences 2023-07-01
Series:	RUHS Journal of Health Sciences
Subjects:	Adverse drug reactions, Covishield, Google forms.
Online Access:	https://ruhsjhs.in/articleDetails.php?artid=TmpBPQ==

Similar Items

A Cross-sectional Study to Assess the Incidence of Adverse Drug Reactions to the Covishield Vaccine among Healthcare Workers of a Tertiary Care Government Institute in North India
by: Kamal Kant TRIVEDI, et al.
Published: (2023-06-01)

Adverse effects after first and second dose of covishield and covaxin: A longitudinal study
by: Amit Mittal, et al.
Published: (2022-01-01)

Assessment of adverse events following first dose of COVISHIELD in healthcare workers of a tertiary care hospital in western Uttar Pradesh: A prospective observational study
by: Shivangna Singh, et al.
Published: (2022-05-01)

Prevalence and determinants of adverse events following ChAdOx1 nCoV-19 vaccination (COVISHIELD) – A retrospective cohort study among healthcare workers in central Karnataka, India
by: Shubha B Davalagi, et al.
Published: (2023-01-01)

Profile of adverse events following COVID-19 vaccination: Insights from Covishield, Covaxin, and Corbevax beneficiaries in India
by: Shivaji B. Kashte, et al.
Published: (2023-01-01)

Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield: A literature review
by: Ayush Kumar, et al.
Published: (2022-01-01)

A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin)
by: Neerja Saraswat, et al.
Published: (2023-01-01)

COVISHIELD vaccine-induced thyroiditis: a case report
by: J. Sachin, et al.
Published: (2023-12-01)

Assessment of adverse drug reactions in oral cancer patients receiving chemotherapy treatment at tertiary care centres in North-Western India
by: Sharma Kopal, et al.
Published: (2023-01-01)

Study on adverse event following COVID 19 vaccination at tertiary care hospital, Karwars
by: Kolur Ashwini M., et al.
Published: (2023-01-01)

Post-vaccination symptoms of covishield vaccine among frontline workers of a tertiary care center in Pathanamthitta District
by: Sahya S Dev, et al.
Published: (2023-01-01)

Atypical facial onset Guillain-Barré syndrome following first dose of COVISHIELD vaccine
by: R.V. Aravinda, et al.
Published: (2021-09-01)

Covishield vaccination and pulmonary thromboembolism: A coincidence or a causal association?
by: Rijal Divas, et al.
Published: (2023-06-01)

Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
by: Manila Purushottam, et al.
Published: (2023-01-01)

Semen characteristics of individuals before and after Covishield™ vaccination
by: Huidrom Yaiphaba Meitei, et al.
Published: (2022-09-01)

Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses
by: Walter de Araujo Eyer-Silva, et al.
Published: (2022-05-01)

Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine
by: Meenakshi Sindhu, et al.
Published: (2023-01-01)

Quantitative estimation of anti-spike SARS-CoV-2 IgG antibody response after covishield vaccination in healthcare workers
by: Megha Goyal, et al.
Published: (2022-01-01)

COVID vaccines: A step towards ending the pandemic
by: Atul Kakar, et al.
Published: (2021-01-01)

Incidence of early adverse events following covishield (ChAdOx1 nCoV-19) vaccination: A prospective study
by: Gajanan D Velhal, et al.
Published: (2022-01-01)

Stimulated Reporting of Adverse Events Following Immunization with COVID-19 Vaccines
by: Ratinder Jhaj, et al.
Published: (2022-12-01)

Complexities of Covishield Vaccine on COVID-Positive History Family in India after the Second (Booster) Dose
by: Parikshit Gautam Jamdade, et al.
Published: (2022-01-01)

Palatal petechiae: an uncommon oral adverse effect of COVID-19 vaccine
by: Bhawna Sayare, et al.
Published: (2021-09-01)

Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield<sup>®</sup>) in Patients with Liver Cirrhosis
by: Amit Goel, et al.
Published: (2022-10-01)

A Comparative Study of Active and Passive Adverse Drug Reaction Monitoring Methods in Category I Tuberculosis Patients at a Tertiary Care Hospital in India
by: Alka Bansal, et al.
Published: (2020-12-01)

Adverse events following immunization to booster dose (precautionary dose) of COVID-19 vaccine among health-care professionals in a tertiary care teaching institute
by: Kandula Chaitanya, et al.
Published: (2023-06-01)

Rational Organisation of Adverse Drug Reaction Monitoring
by: L. V. Shukil, et al.
Published: (2022-10-01)

Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study
by: Nishat Jahan, et al.
Published: (2021-10-01)

COVID-19 : Embolie Pulmonaire aigue sous le vaccin Covishield à l’Hôpital du Mali Aout 2021.
by: D Traore, et al.
Published: (2023-06-01)

A rare case of bilateral optic neuritis post-Covishield (ChAdOx1-S [recombinant]) vaccination
by: Tanie Natung, et al.
Published: (2023-01-01)

An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital
by: Saloni Amin, et al.
Published: (2018-01-01)

Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational studyResearch in context
by: Mangaiarkarasi S. Asokan, et al.
Published: (2024-03-01)

Pattern of Donor Adverse Reactions in Blood Donation in a Tertiary Care Hospital in Bangalore, India
by: M Beulah, et al.
Published: (2023-07-01)

Adverse transfusion reactions following transfusion of blood and blood products in a tertiary care hospital: A step toward hemovigilance
by: Mrigen Choudhury, et al.
Published: (2024-03-01)

Analysis of adverse reactions with phenytoin and carbamazepine in tertiary care hospital – A retrospective study
by: Syed Arshaduddin Ahmed1 , Mohammed Abid Ali2 , T S Usha Sree3 , Margaret Viola4 , Shaima Zafer Khan 5
Published: (2019-04-01)

Effect of concomitant HIV infection on adverse drug reactions by first line antitubercular drugs - a case series analysis
by: Alka Bansal, et al.
Published: (2020-10-01)

Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
by: Shashidhar Jaggaiahgari, et al.
Published: (2022-12-01)

EVALUATIONS OF ADVERSE DRUGS REACTIONS IN RUSSIA IN 2013
by: V. A. Merkulov, et al.
Published: (2022-05-01)

Adverse blood transfusion reaction reporting at a tertiary care hospital, Bhutan
by: Tshering Yangdon, et al.
Published: (2023-01-01)

Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
by: Narayan Prasad, et al.
Published: (2022-06-01)